Ouros rates Soflopeptides 17/100 (evidence still limited). Soflopeptides runs on a burner email and parked domain Based on 1 report, last reviewed Jul 31, 2026.
1 published report on file
Get an email if a new report comes in on Soflopeptides. No spam, unsubscribe anytime.
Based on user-submitted reports. Ouros Lab publishes reports, it does not adjudicate. To request a correction, email hello@ouroslab.co, submit a report, or request a fresh investigation.
Short buyer notes and first-hand reports from the community.
No feedback notes have been shared yet.
Have first-hand experience with this seller?